Select your Region     
Therapeutic Strategies in Targeted Therapies in Breast Cancer

Price: £49.99
· In-depth review of available targeted therapies, covering the main breast cancer subtypes · Addresses possible future development in combination therapies and the role of pharmacogenetics · Appraises current thinking in relation to clinical practice
Edited by:
George W. Sledge, Jr., Chief, Division of Oncology, Stanford School of Medicine, Palo Alto, Calif., USA. José Baselga, Physician-In-Chief, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
This new volume updates the reader on selected areas of targeted therapy in breast cancer, with special emphasis on chemoprevention strategies, drug resistance, biomarkers, combination chemotherapy, angiogenesis inhibition and pharmacogenomics in the context of clinical efficacy. This selected review of targeted therapies will guide the reader on effective treatment as part of an integrated programme of patient management.
Oncologists ▪ Clinical scientists ▪ Doctors in training ▪ Hospital pharmacists

Book Details:
978 1 84692 066 0
128pp; 240 x 170mm; Illustrations; Hardback;
Publication Date: May 2013

Privacy Policy | Terms and Conditions of Sale